EPSTEIN ROBERT S Insider Trades

Insider Trading History

Track insider trading activity for EPSTEIN ROBERT S. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Veracyte
Veracyte VCYT
Director
Holding Value $2.55M 52,446 shares
Last Trade
May 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$440k 10,000 shares
$44.01
$48.69
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $0 0 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59k 25,000 shares
$2.36
$2.22
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $80.7k 36,331 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59k 25,000 shares
$2.36
$2.22
Veracyte
Veracyte VCYT
Director
Holding Value $0 0 shares
Last Trade
Oct 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$362k 10,000 shares
$36.21
$48.69
Veracyte
Veracyte VCYT
Director
Holding Value $4.09M 83,919 shares
Last Trade
Oct 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$362k 10,000 shares
$36.21
$48.69
Veracyte
Veracyte VCYT
Director
Holding Value $3.04M 62,446 shares
Last Trade
Oct 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$753k 21,473 shares
$35.08
$48.69
Veracyte
Veracyte VCYT
Director
Holding Value $3.6M 73,919 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 9,321 shares
$26.82
$48.69
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $122k 55,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$2.22
Illumina
Illumina ILMN
Director
Holding Value $3.78M 22,139 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 3,780 shares
$79.37
$170.93
Veracyte
Veracyte VCYT
Director
Holding Value $0 0 shares
Last Trade
Jan 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$868k 20,000 shares
$43.41
$48.69
Veracyte
Veracyte VCYT
Director
Holding Value $3.15M 64,598 shares
Last Trade
Jan 06, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$868k 20,000 shares
$43.41
$48.69
Veracyte
Veracyte VCYT
Director
Holding Value $974k 20,000 shares
Last Trade
Nov 12, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$574k 15,000 shares
$38.24
$48.69
Veracyte
Veracyte VCYT
Director
Holding Value $2.17M 44,598 shares
Last Trade
Nov 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$575k 15,000 shares
$38.32
$48.69
Veracyte
Veracyte VCYT
Director
Holding Value $2.9M 59,598 shares
Last Trade
Nov 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$574k 15,000 shares
$38.24
$48.69
Veracyte
Veracyte VCYT
Director
Holding Value $2.17M 44,598 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 11,473 shares
$21.79
$48.69
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $88.8k 40,000 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 40,000 shares
$3.68
$2.22
Illumina
Illumina ILMN
Director
Holding Value $3.13M 18,306 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 2,622 shares
$114.46
$170.93
Illumina
Illumina ILMN
Director
Holding Value $2.68M 15,684 shares
Last Trade
May 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$70.4k 612 shares
$115.01
$170.93
Veracyte
Veracyte VCYT
Director
Holding Value $1.61M 33,125 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 9,674 shares
$25.84
$48.69
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $88.8k 40,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 40,000 shares
$5.52
$2.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up